Increased heat generation from atherosclerotic plaques in patients with type 2 diabetes: An increased local inflammatory activation

Diabetes Care

Volumn 28, Issue 7, 2005, Pages 1656-1661

  Toutouzas, Konstantinos ^a,b   Markou, Virginia ^a   Drakopoulou, Maria ^a   Mitropoulos, Ioannis ^a   Tsiamis, Eleftherios ^a   Vavuranakis, Manolis ^a   Vaina, Sophia ^a   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT; PRAVASTATIN; SIMVASTATIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFLAMMATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCUTANEOUS CORONARY INTERVENTION; RISK FACTOR; SMOKING; STABLE ANGINA PECTORIS; THERMOGENESIS; THERMOGRAPHY; ARTERIOSCLEROSIS; BODY TEMPERATURE; COMPARATIVE STUDY; DIABETIC ANGIOPATHY; HEAT; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIOGRAPHY; REFERENCE VALUE; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ARTERIOSCLEROSIS; BODY TEMPERATURE; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HEAT; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLAMMATION; MALE; MIDDLE AGED; REFERENCE VALUES;

EID: 24944514018     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.7.1656     Document Type: Article

References (21)

1. Lim HS, Blann AD, Lip GY: Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention. Circulation 109:2524-2528, 2004
2. Schillinger M, Exner M, Amighi J, Mlekusch W, Sabeti S, Rumpold H, Wagner O, Minar E: Joint effects of C-reactive protein and glycated hemoglobin in predicting future cardiovascular events of patients with advanced atherosclerosis. Circulation 108:2323-2328, 2003
3. Stefanadis C, Diamantopoulos L, Vlachopoulos C, Tsiamis E, Dernellis J, Toutouzas K, Stefanadi E, Toutouzas P: Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo: a new method of detection by application of a special thermography catheter. Circulation 99:1965-1971, 1999
4. Casscells W, Hathorn B, David M, Krabach T, Vaughn WK, McAllister HA, Bearman G, Willerson JT: Thermal detection of cellular infiltrates in living atherosclerotic plaques: possible implications for plaque rupture and thrombosis. Lancet 347:1447-1451, 1996
5. Naghavi M, Madjid M, Gul K, Siadaty MS, Litovsky S, Willerson JT, Casscells SW: Thermography basket catheter: in vivo measurement of the temperature of atherosclerotic plaques for detection of vulnerable plaques. Catheter Cardiovasc Interv 59:52-59, 2003
6. Verheye S, De Meyer GR, Van Langenhove G, Knaapen MW, Kockx MM: In vivo temperature heterogeneity of atherosclerotic plaques is determined by plaque composition. Circulation 105:1596-1601, 2002
7. Stefanadis C, Diamantopoulos L, Dernellis J, Economou E, Tsiamis E, Toutouzas K, Vlachopoulos C, Toutouzas P: Heat production of atherosclerotic plaques and inflammation assessed by the acute phase proteins in acute coronary syndromes. J Mol Cell Cardiol 32:43-52, 2000
8. Toutouzas K, Spanos V, Ribichini F, Michev I, Airoldi F, Orlic D, Chieffo A, Di Mario C, Stefanadis C, Colombo A: A correlation of coronary plaque temperature with inflammatory markers obtained from atherectomy specimens in humans (Abstract). Am J Cardiol 92:476, 2003
9. Stefanadis C, Toutouzas K, Vavuranakis M, Tsiamis E, Tousoulis D, Panagiotakos DB, Vaina S, Pitsavos C, Toutouzas P: Statin treatment is associated with reduced thermal heterogeneity in human atherosclerotic plaques. Eur Heart J 23:1664-1669, 2002
10. Kaushal K, Heald AH, Siddals KW, Sandhu MS, Dunger DB, Gibson JM, Wareham NJ: The impact of abnormalities in IGF and inflammatory systems on the metabolic syndrome. Diabetes Care 27:2682-2688, 2004
11. Nakanishi S, Yamane K, Kamei N, Okubo M, Kohno N: Elevated C-reactive protein is a risk factor for the development of type 2 diabetes in Japanese Americans. Diabetes Care 26:2754-2757, 2003
12. Hashimoto K, Kasayama S, Yamamoto H, Kurebayashi S, Kawase I, Koga M: Strong association of C-reactive protein with body mass index and 2-h post-challenge glucose in non-diabetic, non-smoker subjects without hypertension. Diabet Med 21:581-585, 2004
13. Lu H, Raptis M, Black E, Stan M, Amar S, Graves DT: Influence of diabetes on the exacerbation of an inflammatory response in cardiovascular tissue. Endocrinology 145:4934-4939, 2004
14. Moreno PR, Murcia AM, Palacios IF, Leon MN, Bernardi VH, Fuster V, Fallon JT: Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus. Circulation 102:2180-2184, 2000
15. Shafrir E, Raz I: Diabetes: mellitus or lipidus? Diabetologia 46:433-440, 2003
16. Burke AP, Kolodgie FD, Zieske A, Fowler DR, Weber DK, Varghese PJ, Farb A, Virmani R: Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study. Arteriosder Thromb Vasc Biol 24:1266-1271, 2004
17. Ross R: Atherosclerosis: an inflammatory disease. N Engl J Med 340:115-126, 1999
18. Silva JA, Escobar A, Collins TJ, Ramee SR, White CJ: Unstable angina: a comparison of angioscopic findings between diabetic and nondiabetic patients. Circulation 92:1731-1736, 1995
19. Gurm HS, Lincoff AM, Lee D, Tang WH, Jia G, Booth JE, Califf RM, Ohman EM, Van de Werf F, Armstrong PW, Guetta V, Wilcox R, Topol EJ: Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: lessons from the GUSTO V trial. J Am Coll Cardiol 43:542-548, 2004
20. Toutouzas K, Vaina S, Tsiamis E, Vavuranakis M, Mitropoulos J, Bosinakou E, Toutouzas P, Stefanadis C: Detection of increased temperature of the culprit lesion after recent myocardial infarction: the favorable effect of statins. Am Heart J 148:783-788, 2004
21. Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, Fuller JH: Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 364:685-696, 2004